2025 · 3rd Quarter (July 1 - Sep 30)

AMERICAN ASSOCIATION FOR CANCER RESEARCH

Filed by AMERICAN ASSOCIATION FOR CANCER RESEARCH.

Open official filing

Source-reported fields

Filing overview

Type: 3rd Quarter - Report
Posted: Oct 14, 2025
Income: Not reported
Expenses: $100,000.00
Registrant: AMERICAN ASSOCIATION FOR CANCER RESEARCH
Client: AMERICAN ASSOCIATION FOR CANCER RESEARCH
Filing UUID: 24203cd4-4b7b-4f4d-a549-c5bb9c214bd3
Termination date: Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

BUD · Budget/Appropriations

FY 2026 Appropriations for NIH, NCI, CDC, FDA, and related cancer research and prevention accounts.

MED · Medical/Disease Research/Clinical Labs

Cancer research generally Increasing diversity in clinical trials Drug approval Pediatric cancer detection, treatment, prevention

TOB · Tobacco

Tobacco control and prevention Tobacco cessation

HCR · Health Issues

Reducing cancer disparities Cancer survivorship Preventing HPV-related cancers

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.